Digital Citizens Study Finds Many CBD Products Are Placebos And Most Are Inaccurately Labeled
Executive Summary
Digital Citizens Alliance found an average 30% discrepancy between labeled and actual CBD amounts in nearly 60 products. The group says more than half the products tested contained CBD levels 20% higher or lower than labeled, which is particularly problematic since nearly half US consumers use the products as alternatives to Rx drugs.
You may also be interested in...
Studies Find Oil, Topical And Transdermal Hemp Products’ Content Inconsistent With Labeling
JAMA study found 24% of 89 topicals or transdermals labeled correctly for amounts of cannabinoid in the products; JCR study found 54% of 80 CBD oils were accurately labeled, 15% had higher levels and 31% had lower.
Despite Hot Sales, US CBD Market’s Image Problem Cools Growth, Survey Suggests
US CBD consumers say scams and quality control are greatest concerns, and newer users are most concerned, according to a survey of 780 participants by Bigeye. Results also shed light on factors that could be keeping consumers from trying the products.
HBW Market News: Baze Patents ‘Recommendation Engine,' Built Brands Revamps, Expands Capacity
Leafreport found 54% of 22 beverages contained less CBD than labeled; Built Brands rebrands protein, energy lineup with bigger facility to boost production; Baze Labs’ personalized nutrition “recommendation engine” patented; TruTrace blockchain platform for sanitizer; and Coffeeberry extract GRAS cleared by FDA.